核医学の世界市場動向:核医学診断、核医学治療

RNCOSが発行した調査報告書(RNCS51207)
◆英語タイトル:Global Nuclear Medicine Outlook 2020
◆商品コード:RNCS51207
◆発行会社(リサーチ会社):RNCOS
◆発行日:2015年12月
◆ページ数:75
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,000 ⇒換算¥226,000見積依頼/購入/質問フォーム
Multi-User(全社内共有可)USD2,800 ⇒換算¥316,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はRNCOS社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。RNCOS社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートでは、核医学の世界市場について調査・分析し、市場概要、市場動向、市場展望、核医学の世界市場規模、地域別市場規模、セグメント別市場規模、主要企業分析などの情報をお届けいたします。

・核医学の世界市場:市場概要
・核医学の世界市場:市場動向
・核医学の世界市場:市場展望
・核医学の世界市場:セグメント別市場規模
・核医学の世界市場:地域別市場規模
・核医学の世界市場:主要企業分析

※上記の和訳は最新内容ではない場合があります。
【レポートの概要】

Nuclear Medicine is one of the most promising segments of the medical imaging industry; and is becoming increasingly popular for disease diagnosis and treatment due to safe, painless and cost effective procedures. The Nuclear Medicine has been witnessing a steady demand over the past few years, backed by the worldwide increase in the number of cancer and cardiovascular cases, increasing awareness about early disease detection, and an ever increasing ageing population.

According to our research report, “Global Nuclear Medicine Outlook 2020”, the Global Nuclear Medicine market is anticipated to sustain a robust growth in the coming years also, growing at a CAGR of 9.1% during the forecasted period (2014 to 2020). The market growth is expected mainly due to the application of Nuclear Medicine in the treatment of diseases, with many players investing heavily in the research and development of new therapeutic agents. The report provides information on the current scenario, market segmentation on the basis of application and geography, and future forecasts on all prominent segments of the industry till 2020.

Our segment-level analysis showed that Nuclear Medicine Diagnostics currently holds the biggest share of the total Nuclear Medicine market. However, the segment is expected to witness a slow growth in the future due to competition from conventional technologies like Computed Tomography (CT) and Magnetic Resonance Imaging (MRI), high cost of Nuclear Medicine equipments and shortage of major diagnostic radiopharmaceuticals. Considering the growth rates, the therapeutics segment is expected to grow at a faster rate by 2020 with an increase in use of radiopharmaceuticals for targeted therapy.

Our report has been authored to evaluate the Global Nuclear Medicine market potentials, and identify future growth opportunities. It provides extensive research and analysis on major factors propelling the growth of the industry, challenges holding back the industry, and latest trends and developments in the market.

The report also provides an insight into the market consolidation during 2014 & 2015. With special emphasis on the competitive landscape and dominant players in the market, the research provides valuable information highlighting the opportunities in the Global Nuclear medicine market. The future analysis of the market scenario is likely to assist the intending clients to take informed and proactive business decisions in the evolving Nuclear Medicine market.

【レポートの目次】

1. Analyst View
2. Research Methodology
3. Drivers and Challenges
3.1 Drivers
3.1.1 Rising Incidences of Cancer and Cardiovascular Diseases
3.1.2 Increasing Use of SPECT and PET Scans
3.1.3 Rising Ageing Population
3.1.4 Advances in Radiotracers
3.2 Challenges
3.2.1 Shut Down of Nuclear Reactors
3.2.2 Short Half-life of Radiopharmaceuticals
3.2.3 Production and Quality Control Challenges
3.2.4 Reimbursement Issues
4. Industry Overview
4.1 Nuclear Medicine Diagnostics Market
4.1.1 Diagnostic Radiopharmaceuticals Market
4.1.2 Nuclear Medicine Equipments Market
4.2 Nuclear Medicine Therapeutics Market
4.3 Nuclear Medicine Market by Geography
5. Recent Trends and Developments
5.1 Nuclear Medicine: Aiding the Growth of Personalized Medicine
5.2 Shift from SPECT to PET Systems
5.3 Hybrid Imaging Propelling Market Growth
5.4 Efforts Underway to Overcome Molybdenum-99 Shortage
5.5 Consolidation in the Market
5.6 Increasing Number of Clinical Trials
6. Competitive Landscape
6.1 Advanced Accelerator Applications
6.2 Mallinckrodt
6.3 Lantheus Medical Imaging
6.4 IBA
6.5 Cardinal Health Inc.
6.6 Nordion Inc.
6.7 Siemens Healthcare
6.8 GE Healthcare

List of Figures:

Figure 3-1: World – Number of Cancer Cases (Million), 2015 & 2035
Figure 3-2: World – Population Aged 60 and Above (Billion), 2014 & 2050
Figure 4-1: Global – Nuclear Medicine Market (Billion US$), 2014-2020
Figure 4-2: Nuclear Medicine Market Segmentation by Application (%), 2014
Figure 4-3: Nuclear Medicine Market Segmentation by Application (%), 2020
Figure 4-4: Nuclear Medicine Diagnostics Market Segmentation (%), 2014
Figure 4-5: Nuclear Medicine Diagnostics Market Segmentation (%), 2020
Figure 4-6: Global – Nuclear Medicine Diagnostics Market (Billion US$), 2014-2020
Figure 4-7: Medical Procedures Using Technetium – 99m (%), 2014
Figure 4-8: Global – Diagnostic Radiopharmaceuticals Market (Billion US$), 2014-2020
Figure 4-9: Global – Nuclear Medicine Equipments Market (Billion US$), 2014-2020
Figure 4-10: Global – Nuclear Medicine Therapeutics Market (Billion US$), 2014-2020
Figure 4-11: Global – Nuclear Medicine Market by Geographies (%), 2014

List of Tables:

Table 5-1: Recent M&A in the Global Nuclear Medicine Market (2014 – 2015)
Table 5-2: Major Products in the Pipeline
Table 6-1: Advanced Accelerator Applications – Revenue by Product Category (Million Euro), 2013 & 2014
Table 6-2: Advanced Accelerator Applications – Revenue by Countries (Million Euro), 2013 & 2014
Table 6-3: Advanced Accelerator Applications – Strengths & Weaknesses
Table 6-4: Mallinckrodt – Revenue by Business Segments (Million US$), 2013 & 2014
Table 6-5: Mallinckrodt – Revenue Breakup for Global Medical Imaging Segment (Million US$), 2013 & 2014
Table 6-6: Mallinckrodt – Strengths & Weaknesses
Table 6-7: Lantheus Medical Imaging – Revenue by Products (Million US$), 2013 & 2014
Table 6-8: Lantheus Medical Imaging – Strengths & Weaknesses
Table 6-9: IBA – Revenue by Business Segments (Million Euro), 2013 & 2014
Table 6-10: IBA – Strengths & Weaknesses
Table 6-11: Cardinal Health Inc. – Revenue by Business Segments (Billion US$), 2013 & 2014
Table 6-12: Cardinal Health Inc. – Strengths & Weaknesses
Table 6-13: Nordion Inc. – Strengths & Weaknesses
Table 6-14: Siemens Healthcare – Strengths and Weaknesses
Table 6-15: GE Healthcare – Strengths and Weaknesses



【レポートのキーワード】

核医学診断、核医学診断装置、核医学治療、放射線、医療

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 核医学の世界市場動向:核医学診断、核医学治療(Global Nuclear Medicine Outlook 2020)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆